133 related articles for article (PubMed ID: 10980137)
21. Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia.
Lin MC; Mutter GL; Trivijisilp P; Boynton KA; Sun D; Crum CP
Am J Pathol; 1998 May; 152(5):1313-8. PubMed ID: 9588899
[TBL] [Abstract][Full Text] [Related]
22. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
23. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.
Wistuba II; Behrens C; Milchgrub S; Bryant D; Hung J; Minna JD; Gazdar AF
Oncogene; 1999 Jan; 18(3):643-50. PubMed ID: 9989814
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
25. Widespread molecular alterations present in stage I non-small cell lung carcinoma fail to predict tumor recurrence.
Baksh FK; Dacic S; Finkelstein SD; Swalsky PA; Raja S; Sasatomi E; Luketich JD; Fernando HC; Yousem SA
Mod Pathol; 2003 Jan; 16(1):28-34. PubMed ID: 12527710
[TBL] [Abstract][Full Text] [Related]
26. Alterations of 9p in squamous cell carcinoma and adenocarcinoma of the lung: association with smoking, TP53, and survival.
Marsit CJ; Wiencke JK; Nelson HH; Kim DH; Hinds PW; Aldape K; Kelsey KT
Cancer Genet Cytogenet; 2005 Oct; 162(2):115-21. PubMed ID: 16213358
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
28. Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.
Iijima H; Tomizawa Y; Dobashi K; Saito R; Nakajima T; Mori M
Br J Cancer; 2004 Sep; 91(6):1143-8. PubMed ID: 15292942
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
30. LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer.
Sanz-Ortega J; Bryant B; Sanz-Esponera J; Asenjo JA; Saez MC; Torres A; Balibrea JL; Sobel ME; Merino MJ
Pathol Res Pract; 1999; 195(10):677-80. PubMed ID: 10549031
[TBL] [Abstract][Full Text] [Related]
31. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
Varella-Garcia M; Gemmill RM; Rabenhorst SH; Lotto A; Drabkin HA; Archer PA; Franklin WA
Cancer Res; 1998 Oct; 58(20):4701-7. PubMed ID: 9788625
[TBL] [Abstract][Full Text] [Related]
35. Comparison of features of human lung cancer cell lines and their corresponding tumors.
Wistuba II; Bryant D; Behrens C; Milchgrub S; Virmani AK; Ashfaq R; Minna JD; Gazdar AF
Clin Cancer Res; 1999 May; 5(5):991-1000. PubMed ID: 10353731
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
[TBL] [Abstract][Full Text] [Related]
37. Genetic analyses of non-small cell lung cancer in Jewish Israeli patients.
Schayek H; Krupsky M; Yaron P; Yellin A; Simansky DA; Friedman E
Isr Med Assoc J; 2006 Mar; 8(3):159-63. PubMed ID: 16599049
[TBL] [Abstract][Full Text] [Related]
38. Comparative allelotype of early and advanced stage non-small cell lung carcinomas.
Shiseki M; Kohno T; Adachi J; Okazaki T; Otsuka T; Mizoguchi H; Noguchi M; Hirohashi S; Yokota J
Genes Chromosomes Cancer; 1996 Oct; 17(2):71-7. PubMed ID: 8913723
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma.
Aoyagi Y; Yokose T; Minami Y; Ochiai A; Iijima T; Morishita Y; Oda T; Fukao K; Noguchi M
Cancer Res; 2001 Nov; 61(21):7950-4. PubMed ID: 11691817
[TBL] [Abstract][Full Text] [Related]
40. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]